Fidelity Disruptive Medicine ETF (NASDAQ:FMED) Short Interest Update

Posted by Renee Jackson on May 30th, 2026

Fidelity Disruptive Medicine ETF (NASDAQ:FMED – Get Free Report) saw a significant decline in short interest in the month of May. As of May 15th, there was short interest totaling 295 shares, a decline of 61.7% from the April 30th total of 770 shares. Based on an average daily volume of 64,427 shares, the days-to-cover ratio is currently 0.0 days. Approximately 0.0% of the company’s shares are short sold.

Fidelity Disruptive Medicine ETF Stock Down 0.4%

NASDAQ:FMED opened at $25.17 on Friday. Fidelity Disruptive Medicine ETF has a 52 week low of $22.80 and a 52 week high of $29.07. The company has a market capitalization of $57.89 million, a P/E ratio of 41.33 and a beta of 0.84. The stock’s fifty day moving average is $24.84 and its two-hundred day moving average is $26.17.

Institutional Investors Weigh In On Fidelity Disruptive Medicine ETF

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Glass Jacobson Investment Advisors llc raised its position in Fidelity Disruptive Medicine ETF by 44.0% in the fourth quarter. Glass Jacobson Investment Advisors llc now owns 1,260 shares of the company’s stock valued at $34,000 after purchasing an additional 385 shares during the period. Virtu Financial LLC purchased a new stake in Fidelity Disruptive Medicine ETF in the fourth quarter valued at $228,000. Vise Technologies Inc. purchased a new stake in Fidelity Disruptive Medicine ETF in the fourth quarter valued at $234,000. BXM Wealth LLC purchased a new stake in Fidelity Disruptive Medicine ETF in the fourth quarter valued at $243,000. Finally, Jane Street Group LLC raised its position in Fidelity Disruptive Medicine ETF by 0.8% in the first quarter. Jane Street Group LLC now owns 66,382 shares of the company’s stock valued at $1,567,000 after purchasing an additional 499 shares during the period.

Fidelity Disruptive Medicine ETF Company Profile

(Get Free Report)

The Fidelity Disruptive Medicine ETF (FMED) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed fund that invests in companies involved in disruptive innovation in Health Care. The fund invests in securities of domestic and foreign issuers FMED was launched on Apr 16, 2020 and is managed by Fidelity.